MLchartDataset catalogue

Poseltinib

Term · Oncology and biomedicine · MLC-T-ONC-016188

An inhibitor of Bruton's tyrosine kinase (BTK) with potential anti-inflammatory activity. Upon administration, poseltinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents the activation of BTK-mediated inflammatory pathways.

Table 1. Record
IdentifierMLC-T-ONC-016188
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016188",
  "term": "Poseltinib",
  "field": "Oncology and biomedicine",
  "definition": "An inhibitor of Bruton's tyrosine kinase (BTK) with potential anti-inflammatory activity. Upon administration, poseltinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents the activation of BTK-mediated inflammatory pathways.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/poseltinib/"
}

Record 13,504 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.